New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
scPharmaceuticals Inc.
SCPH
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

209M

Biotechnology

Next Earning date - 13 Nov 2024

209M

Biotechnology

Next Earning date - 13 Nov 2024

4.18USD
Shape-0.19 ( -4.35%)
favorite-chart

Relative Strenght

7
favorite-chart

Volume Buzz

12%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

38%

Quote Panel

Shape
Updated October 24, 2024
1W -7.73 % 1M -9.91 % 3M -16.06 % 1Y -28.42 %

Key Metrics

Shape
  • Market Cap

    209.12M


  • Shares Outstanding

    50.03M


  • Share in Float

    35.23M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    4.18


  • Average Volume

    301745


  • Beta

    0.122


  • Range

    3.24-6.71


  • Industry

    Biotechnology


  • Website

    https://www.scpharmaceuticals.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

8.84x

P/S Ratio

17.91x

P/B Ratio

4.3

Debt/Equity

-252.2%

Net Margin

$-1.6

EPS

How SCPH compares to sector?

P/E Ratio

Relative Strength

Shape

SCPH

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$97M

Shape1099%

2025-Revenue

$0.73

Shape-66%

2025-EPS

$58M

Shape503%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

SVB Leerink

upgrade

Previous: Not converted

2022-10-11

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.37
vs -0.24

Q4.22

arrow
arrow

N/A

-0.30
vs -0.27

Q1.23

arrow
arrow

N/A

-0.34
vs -0.30

Q2.23

arrow
arrow

N/A

NA
vs NA

Q3.23

arrow
arrow

N/A

-0.41
vs -0.37

Q4.23

arrow
arrow

N/A

-0.35
vs -0.30

Q1.24

arrow
arrow

N/A

-0.36
vs -0.34

Q2.24

arrow
arrow

N/A

-0.44
vs NA

Q3.24

arrow
arrow

N/A

-0.30
vs -0.41

Q4.24

arrow
arrow

N/A

-0.27
vs -0.35

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

2.1M  vs NA

Q2.23

arrow
arrow

NA

1.6M  vs NA

Q3.23

arrow
arrow

NA

3.8M  vs NA

Q4.23

arrow
arrow

NA

6.1M  vs NA

Q1.24

arrow
arrow

+196%

6.1M  vs 2.1M

Q2.24

arrow
arrow

+392%

8.1M  vs 1.6M

Q3.24

arrow
arrow

+185%

10.8M  vs 3.8M

Q4.24

arrow
arrow

+138%

14.5M  vs 6.1M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-33%

-0.33
vs -0.25

Q4.22

arrow
arrow

+4%

0.04
vs -0.33

Q1.23

arrow
arrow

+5%

0.05
vs 0.04

Q2.23

arrow
arrow

+6%

0.06
vs 0.05

Q3.23

arrow
arrow

-32%

-0.32
vs 0.06

Q4.23

arrow
arrow

-37%

-0.37
vs -0.32

Q1.24

arrow
arrow

-57%

-0.57
vs -0.37

Q2.24

arrow
arrow

-185%

-1.85
vs -0.57

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

39

39
vs 36

8%

Q4.22

arrow
arrow

62

62
vs 39

59%

Q1.23

arrow
arrow

66

66
vs 62

6%

Q2.23

arrow
arrow

85

85
vs 66

29%

Q3.23

arrow
arrow

77

77
vs 85

-9%

Q4.23

arrow
arrow

85

85
vs 77

10%

Q1.24

arrow
arrow

81

81
vs 85

-5%

Q2.24

arrow
arrow

79

79
vs 81

-2%

Earnings Growth

Latest News